Simian Acquired Immunodeficiency Syndrome
- Vaccines and Antiviral Agents | SpotlightVector Order Determines Protection against Pathogenic Simian Immunodeficiency Virus Infection in a Triple-Component Vaccine by Balancing CD4+ and CD8+ T-Cell Responses
- Pathogenesis and ImmunityPathogenic Correlates of Simian Immunodeficiency Virus-Associated B Cell Dysfunction
- Virus-Cell InteractionsInterferon-Inducible CD169/Siglec1 Attenuates Anti-HIV-1 Effects of Alpha Interferon
- Cellular Response to InfectionOn the Death Rate of Abortively Infected Cells: Estimation from Simian-Human Immunodeficiency Virus Infection
- Vaccines and Antiviral AgentsVirological Control by the CD4-Binding Site Antibody N6 in Simian-Human Immunodeficiency Virus-Infected Rhesus Monkeys